Chylothorax Diagnosis and Management

Diagnostic Criteria

The American College of Radiology recommends that a change from serosanguinous to milky chest tube drainage indicates chylothorax until proven otherwise, requiring immediate fluid analysis for triglycerides and chylomicrons to confirm the diagnosis 1, 2, 3
Triglyceride levels >110 mg/dL confirm chylothorax, while levels <50 mg/dL effectively exclude it, according to the American College of Radiology 1, 2, 3, 4
Lipoprotein analysis for chylomicrons is required when triglycerides are 50-110 mg/dL or in fasting/malnourished patients even with lower values, as recommended by the American College of Radiology 1, 2
The pleural fluid to serum cholesterol ratio <1.0 distinguishes true chylothorax from pseudochylothorax, according to the American College of Radiology 1, 4

True chylothorax is characterized by triglycerides >110 mg/dL, chylomicrons present, and cholesterol <200 mg/dL, as defined by the Thorax journal 2, 3
Pseudochylothorax (cholesterol pleurisy) is characterized by cholesterol >200 mg/dL, no chylomicrons, and cholesterol crystals on microscopy, typically from chronic effusions with thickened pleura, according to the Thorax journal 2, 3
Empyema can appear milky but clears with centrifugation, whereas chylous effusion remains milky, as noted in the Thorax journal 2, 3

Traumatic causes of chylothorax account for 54% of cases, including post-surgical and chest trauma, according to the American College of Radiology 1, 4
Non-traumatic causes of chylothorax account for 46% of cases, including malignancy (50% of non-traumatic, particularly lymphoma), tuberculosis, sarcoidosis, and amyloidosis, as reported by the American College of Radiology 1, 2, 3

The American College of Radiology recommends conservative management as the first-line treatment for 2 weeks, including continued chest tube drainage, dietary modification, and replacement of fluid and protein losses 1, 4
Invasive treatment is indicated if conservative treatment fails after 2 weeks, or if there is high-output chylothorax or underlying malignancy, according to the American College of Radiology 1, 4
Invasive options include thoracic duct embolization, surgical thoracic duct ligation, and pleurodesis, as recommended by the American College of Radiology 1, 4

The American College of Radiology recommends not delaying beyond 2-3 weeks of conservative therapy, as prolonged chyle leak causes progressive deterioration 1